EFPIA Newsletter 12 January 2023

News     15 December 2022 EFPIA survey among member companies on compliance with the EFPIA-PHRMA principles for responsible... EFPIA members continue to be committed to responsible clinical trial data sharing, for the benefit of patients and researchers... Read more →

Blogs     19 December 2022 How to make the European Health Data Space a reality? If the EU's vision is to be more than a dream, there must be action in the form of an agreement between the EU 27 Member... Read more →

The Power of Innovation

January is Cervical Cancer Awareness Month. The HPV vaccine reduces cervical cancer risk by almost 100%. That’s millions of families not losing a sister, daughter, or mother. Find out more #WeWontRest

Events     18 JAN 2023   IHI Call Days - Call 4 Virtual event Join the webinar to get information on how to apply and to meet potential partners for consortia. Learn more →       18 JAN 2023   Understanding Net Pharmaceutical Expenditure Dynamics in Europe Virtual event An IQVIA webinar Learn more →

	25 JAN 2023			RETHINKING THE FUTURE OF CANCER CARE Virtual event Organised in partnership with the FT Live Learn more →

	31 JAN 2023			Even spaceships need a launchpad Virtual event Bring the regulatory framework for innovative medicines into the future Learn more →

Podcasts Why is a therapeutics waiver extension different to the vaccine waiver? 08 December 2022 (News & Events) While the goals of ramping up production and improving access are valid ones, not only is a waiver extension not needed,... Read more → Podcast: What would a TRIPS waiver extension mean for diagnostics? 01 December 2022 (News & Events) Listen to EFPIA's latest podcast. Read more →

What we are reading Research and Development in the Pharmaceutical Industry 09 January 2023  (Pfizer) Read more → Swedish EU Presidency Promises Action On Pharma Law Revision, EMA Fees & AMR 05 January 2023  (Pink Sheet) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe